NSE filing, NSE: DHANSA. Summary written from the filing by ALFA Finder's alert engine.
Dhansa Labs Ltd: key numbers
- Share price
- ₹25.20
- Market cap
- ₹67.80 Cr
- Revenue (annual)
- ₹141.5 Cr
- Net profit (annual)
- ₹5.73 Cr
- P/E (TTM)
- 11.8×Sector 34.1×
- Promoter holding
- 65.05%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dhansa Labs Ltd
All →Dhansa Labs Annual General Meeting
Dhansa Labs Limited held its 41st Annual General Meeting on September 26, 2026, to adopt financial statements and ratify the cost auditor's remuneration.
Dhansa Labs Annual General Meeting
Dhansa Labs Limited announced the voting results for its postal ballot. Shareholders approved the alteration of the object clause, asset mortgage/disposal, and a related party transaction.
Dhansa Labs Annual General Meeting
Dhansa Labs Limited issued a notice for its Annual General Meeting scheduled for September 26, 2026. Agenda items include financial statement adoption and director reappointment.
- Value
- ₹0.01 Cr
Dhansa Labs Annual General Meeting
Dhansa Labs Limited approved the notice for its 41st Annual General Meeting and the Director's Report for the financial year ending March 31, 2026.
Dhansa Labs Business Update
Dhansa Labs' wholly owned subsidiary, Dhansa Green Energy, conducted the groundbreaking ceremony for a 15 TPD Compressed Biogas project in Rajasthan.
Dhansa Labs Capital Structure Change
Dhansa Labs received listing and trading approval for 19,56,521 equity shares allotted upon conversion of warrants on a preferential basis.
Other other announcement announcements
All →STL Networks Other Announcement
The Monitoring Agency reported Rs. 2 Crore utilization of Preferential Issue proceeds, with no deviations from objects. The report covers the quarter ending September 30, 2026.
HEG Advanced Materials Other Announcement
HEG Advanced Materials Limited has intimated the exchange regarding the change of its Corporate Identification Number (CIN) following an approved scheme of arrangement.
Sanofi India Other Announcement
Sanofi India issued a communication regarding Tax Deduction at Source (TDS) for the interim dividend declared for FY 2026. Shareholders must update details by November 5, 2026.
Visaka Industries Other Announcement
Visaka Industries informed the exchange about sending reminder letters to shareholders regarding the compulsory transfer of unclaimed dividends and equity shares to the IEPF account.
Arvaya Healthcare Other Announcement
Arvaya Healthcare filed its quarterly shareholding pattern under Regulation 31(1)(c). The filing reports routine ownership breakdowns with no transaction.
AYM Syntex Other Announcement
AYM Syntex's board appointed BSR & Co. LLP as statutory auditor for five years, subject to shareholder approval. Routine auditor appointment; no monetary value involved.
- Execution
- Five consecutive years, from the conclusion of the 44th AGM to the conclusion of the 49th AGM